{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:47:12Z","timestamp":1791499632555,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273288"],"award-info":[{"award-number":["82273288"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.euo.2025.03.004","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T16:48:22Z","timestamp":1744735702000},"page":"899-908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development and Validation of the UriMee Model: A Methylation-based Diagnostic Tool for Early Diagnosis of Urothelial Carcinoma"],"prefix":"10.1016","volume":"8","author":[{"given":"Ming","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haige","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.03.004_b0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.03.004_b0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2023 update","volume":"84","author":"Roupr\u00eat","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.03.004_b0015","article-title":"Inherited mutations in Chinese patients with upper tract urothelial carcinoma","volume":"4","author":"Wu","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.euo.2025.03.004_b0020","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2025.03.004_b0025","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2009.06.028","article-title":"Recurrence and progression of disease in non\u2013muscle-invasive bladder cancer: from epidemiology to treatment strategy","volume":"56","author":"van Rhijn","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.03.004_b0030","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1007\/s00345-020-03569-2","article-title":"Follow-up in non-muscle invasive bladder cancer: facts and future","volume":"39","author":"Witjes","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.03.004_b0035","doi-asserted-by":"crossref","first-page":"66.e25","DOI":"10.1016\/j.urolonc.2014.06.008","article-title":"Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer","volume":"33","author":"Yafi","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.03.004_b0040","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.3390\/diagnostics12112696","article-title":"Detection of urinary molecular marker test in urothelial cell carcinoma: a review of methods and accuracy","volume":"12","author":"Bulai","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.euo.2025.03.004_b0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41585-023-00773-8","article-title":"Urine biomarkers in bladder cancer\u2014current status and future perspectives","volume":"20","author":"Maas","year":"2023","journal-title":"Nat Rev Urol"},{"issue":"178","key":"10.1016\/j.euo.2025.03.004_b0050","first-page":"91","article-title":"Methylation biomarkers for early cancer detection and diagnosis: current and future perspectives","volume":"2023","author":"Ibrahim","year":"1990","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euo.2025.03.004_b0055","first-page":"376","article-title":"Cancer epigenetics in clinical practice","volume":"73","author":"Davalos","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2025.03.004_b0060","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.euf.2024.05.024","article-title":"Diagnostic test accuracy of urinary DNA methylation-based biomarkers for the detection of primary and recurrent bladder cancer: a systematic review and meta-analysis","volume":"10","author":"Silva-Ferreira","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.03.004_b0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11934-018-0861-5","article-title":"Epigenetic alterations in bladder cancer","volume":"19","author":"Porten","year":"2018","journal-title":"Curr Urol Rep"},{"issue":"3 Pt 1","key":"10.1016\/j.euo.2025.03.004_b0070","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.juro.2016.09.118","article-title":"Validation of a DNA methylation-mutation urine assay to select patients with hematuria for cystoscopy","volume":"197","author":"van Kessel","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.03.004_b0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-024-01974-4","article-title":"Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trial","volume":"23","author":"Wu","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.euo.2025.03.004_b0080","doi-asserted-by":"crossref","first-page":"342.e15","DOI":"10.1016\/j.urolonc.2018.04.001","article-title":"Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: a prospective, single-center study","volume":"36","author":"Guo","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.03.004_b0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13148-021-01073-x","article-title":"A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer","volume":"13","author":"Ruan","year":"2021","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.euo.2025.03.004_b0090","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.euf.2018.09.016","article-title":"HOXA9, PCDH17, POU4F2, and ONECUT2 as a urinary biomarker combination for the detection of bladder cancer in Chinese patients with hematuria","volume":"6","author":"Wu","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.03.004_b0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.euo.2018.06.011","article-title":"Performance of the bladder EpiCheckTM methylation test for patients under surveillance for non-muscle-invasive bladder cancer: results of a multicenter, prospective, blinded clinical trial","volume":"1","author":"Witjes","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.03.004_b0100","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.juro.2015.08.085","article-title":"Evaluation of an epigenetic profile for the detection of bladder cancer in patients with hematuria","volume":"195","author":"van Kessel","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.03.004_b0105","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1186\/s12885-015-1777-9","article-title":"Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation","volume":"15","author":"Rauscher","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euo.2025.03.004_b0110","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s12967-024-05146-2","article-title":"Novel genome-wide DNA methylation profiling reveals distinct epigenetic landscape, prognostic model and cellular composition of early-stage lung adenocarcinoma","volume":"22","author":"Gan","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.euo.2025.03.004_b0115","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/1471-2164-12-313","article-title":"Chromosome-wide mapping of DNA methylation patterns in normal and malignant prostate cells reveals pervasive methylation of gene-associated and conserved intergenic sequences","volume":"12","author":"Yegnasubramanian","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1016\/j.euo.2025.03.004_b0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41586-019-1534-3","article-title":"The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape","volume":"573","author":"Weinberg","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.euo.2025.03.004_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.832348","article-title":"Intragenic CpG islands and their impact on gene regulation","volume":"10","author":"Cain","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.euo.2025.03.004_b0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euo.2025.03.004_b0135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrurol.2016.252","article-title":"Diagnostic dilemmas in patients with upper tract urothelial carcinoma","volume":"14","author":"Baard","year":"2017","journal-title":"Nat Rev Urol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:25:04Z","timestamp":1758079504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2588931125000793"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.03.004","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and Validation of the UriMee Model: A Methylation-based Diagnostic Tool for Early Diagnosis of Urothelial Carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}